News

FebriDx® Featured in Australian Doctor

14 February 2025
General practitioners (GPs) routinely assess conflicting symptoms of respiratory illness in their patients - and on the balance of available information and clinical judgement, often prescribe antibiotics on the spot.

As featured in an article by journalist Rachel Fieldhouse for Australian Doctor - ‘New point-of-care tests promise to pick the patients who actually need antibiotics’- Lumos’ FebriDx® rapid point-of-care diagnostic test is now approved and ready to help in Australia.

FebriDx® enables healthcare professionals to distinguish between bacterial infections and non-bacterial etiology, supporting informed decisions about antibiotic prescriptions.

Lumos Non-Executive Chair, Sam Lanyon, was interviewed for the article, reflecting on Lumos’ consultation with the Australian medical community.

“A fast, cost-effective point-of-care test would be useful to help them provide the evidence to a patient that they don’t need antibiotics and they’re not going to be effective,” he said.

“In the Australian and US context, we had exactly the same feedback. [Doctors] all articulate the same problem.”

Click here to read the article

Inquire now

We are inviting qualified B2B Service inquiries for those seeking to develop point-of-care reader technology

By entering your email address you are agreeing to our Privacy Policy.